1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Blood Bags Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of road accidents and trauma cases creating need for blood
5.1.1.2. Government initiatives encouraging blood donations and rising need for safe blood storage and transportation services
5.1.2. Restraints
5.1.2.1. Harmful waste produced due to usage of blood bags along with adverse impact of PVC material
5.1.3. Opportunities
5.1.3.1. Advancements in the blood bags field
5.1.3.2. Increasing number of blood banks globally
5.1.4. Challenges
5.1.4.1. Managing the blood safety during transfusion and complex requirement of maintaining precise blood bag temperature
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing demand for single blood bags as they are cost-effective and straightforward compared to multi-component alternatives
5.2.2. End-Use: Significant use of blood bags by the blood blanks
5.2.3. Usability: Growing popularity of transfer bags for securely transport blood samples
5.2.4. Material: Rising adoption of polyvinyl chloride (PVC) due to its high durability and lightweight properties
5.3. Market Trend Analysis
5.3.1. Well-established regulatory standards for blood bags in the Americas
5.3.2. Surge in blood donation activities and significant presence of blood bag manufacturers in the APAC region
5.3.3. Ongoing product developments and encouraging blood donation initiatives expand the market growth in the EMEA region
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
6. Blood Bags Market, by Type
6.1. Introduction
6.2. Double
6.3. Quadruple
6.4. Single
6.5. Triple
7. Blood Bags Market, by Material
7.1. Introduction
7.2. Polyethylene Terephthalate
7.3. Polyolefins
7.4. Polyvinyl Chloride
8. Blood Bags Market, by Usability
8.1. Introduction
8.2. Collection Bag
8.3. Transfer Bag
9. Blood Bags Market, by End-Use
9.1. Introduction
9.2. Blood Banks
9.3. Hospital
10. Americas Blood Bags Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Blood Bags Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Blood Bags Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Agreement, Collaboration, & Partnership
13.3.1.1. Maco Medlab: Joint-Venture of 2 blood transfusion players
13.3.1.2. U.S. Gov awards USD 10.6 Million Freeze-Dried Plasma Contract to Terumo
13.3.2. New Product Launch & Enhancement
13.3.2.1. BetaLife to Showcase Its AI Powered Health Tech Solution for Advancing Health Equity at GITEX AFRICA 2023 The Largest Tech Event
13.3.2.2. ICMR Runs Trial of Blood Bag Delivery Under iDrone Initiative
13.3.2.3. Trial Run of Blood Bag Delivery under the iDrone Initiative of ICMR successfully conducted
13.3.2.4. DBT Institute Develops Novel Bags To Increase Shelf Life Of Blood
13.3.3. Investment & Funding
13.3.3.1. For Start-Ups, Industry, Kerala Doubles Financial Assistance to INR 10 Million
13.3.3.2. NBSC Calls for Investment in Blood Bank
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AdvaCare Pharma
14.1.2. Advin Health Care
14.1.3. Alvedia
14.1.4. B L Lifesciences Private Limited
14.1.5. Demophorius Limited
14.1.6. Fresenius SE & Co. KGaA
14.1.7. Grifols, S.A
14.1.8. HAEMONETICS CORPORATION
14.1.9. HLL Lifecare Limited
14.1.10. HÄNSLER MEDICAL GMBH
14.1.11. Inovet
14.1.12. JMS Co., Ltd.
14.1.13. KIEFEL GmbH
14.1.14. Lmb Technologie GmbH
14.1.15. Maco Pharma SAS
14.1.16. Mitra Industries Pvt. Ltd.
14.1.17. Narang Medical Limited
14.1.18. Neomedic
14.1.19. Olidef Medical
14.1.20. Poly Medicure Limited
14.1.21. Qingdao Sinoland International Trade Co., Ltd.
14.1.22. RENOLIT SE
14.1.23. SB-Kawasumi Laboratories, Inc.
14.1.24. Shandong Weigao Group Medical Polymer Co.,Ltd.
14.1.25. Suru International Pvt. Ltd.
14.1.26. Suzhou Sinomed Co., Ltd.
14.1.27. Terumo Corporation
14.1.28. The Metrix Company
14.1.29. TROGE MEDICAL GmbH
14.1.30. Xindray Medical International Co., Ltd.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer